Fibroblast growth factor signaling in tumorigenesis

Cytokine and Growth Factor Reviews

Volumn 16, Issue 2 SPEC. ISS., 2005, Pages 179-186

  Grose, Richard ^a   Dickson, Clive ^a  

^a IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

Author keywords

Cancer; FGF receptors; FGFs

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; FIBROBLAST GROWTH FACTOR; IMATINIB;

CARCINOGENESIS; CELL DIFFERENTIATION; CELL MOTILITY; CELL PROLIFERATION; HUMAN; LIGAND BINDING; MOLECULAR MODEL; NONHUMAN; PRIORITY JOURNAL; PROSTATE CARCINOMA; REVIEW; SIGNAL TRANSDUCTION; UROGENITAL TRACT TUMOR;

EID: 18144413583     PISSN: 13596101     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cytogfr.2005.01.003     Document Type: Article

References (62)

1. D.M. Ornitz, and N. Itoh Fibroblast growth factors Genome Biol 2 3 2001 3005 (Reviews)
2. W.L. McKeehan, F. Wang, and M. Kan The heparan-sulfate fibroblast growth-factor family - diversity of structure and function Prog Nucleic Acid Res Mol Biol 59 1998 135 176
3. P. Klint, and L. Claesson-Welsh Signal transduction by fibroblast growth factor receptors Front Biosci 4 1999 165 177
4. T. Casci, J. Vinos, and M. Freeman Sprouty, an intracellular inhibitor of Ras signalling Cell 96 5 1999 655 665
5. N. Hacohen, S. Kramer, D. Sutherland, Y. Hiromi, and M.A. Krasnow Sprouty encodes a novel antagonist of FGF signaling that patterns apical branching of the Drosophila airways Cell 92 2 1998 253 263
6. M. Furthauer, W. Lin, S.L. Ang, B. Thisse, and C. Thisse Sef is a feedback-induced antagonist of Ras/MAPK-mediated FGF signalling Nat Cell Biol 4 2 2002 170 174
7. M. Tsang, R. Friesel, T. Kudoh, and I.B. Dawid Identification of Sef, a novel modulator of FGF signalling Nat Cell Biol 4 2 2002 165 169
8. B.G. Ciruna, L. Schwartz, K. Harpal, T.P. Yamaguchi, and J. Rossant Chimeric analysis of fibroblast growth-factor receptor-1 (FGFR1) function - a role for FGFR1 in morphogenetic movement through the primitive streak Development 124 14 1997 2829 2841
9. C.X. Deng, A. Wynshawboris, M.M. Shen, C. Daugherty, D.M. Ornitz, and P. Leder Murine FGFR-1 is required for early postimplantation growth and axial organization Genes Dev 8 24 1994 3045 3057
10. B. Ciruna, and J. Rossant FGF signaling regulates mesoderm cell fate specification and morphogenetic movement at the primitive streak Dev Cell 1 1 2001 37 49
11. T.P. Yamaguchi, K. Harpal, M. Henkemeyer, and J. Rossant FGFR-1 is required for embryonic growth and mesodermal patterning during mouse gastrulation Genes Dev 8 24 1994 3032 3044
12. M. Beiman, B.Z. Shilo, and T. Volk Heartless a Drosophila FGF receptor homolog, is essential for cell migration and establishment of several mesodermal lineages Genes Dev 10 23 1996 2993 3002
13. S. Gisselbrecht, J.B. Skeath, C.Q. Doe, and A.M. Michelson Heartless encodes a fibroblast growth factor receptor (DFR1/DFGF-R2) involved in the directional migration of early mesodermal cells in the Drosophila embryo Genes Dev 10 23 1996 3003 3017
14. L. De Moerlooze, B. Spencer-Dene, J. Revest, M. Hajihosseini, I. Rosewell, and C. Dickson An important role for the IIIb isoform of fibroblast growth factor receptor 2 (FGFR2) in mesenchymal-epithelial signalling during mouse organogenesis Development 127 3 2000 483 492
15. A. Petiot, F.J. Conti, R. Grose, J.M. Revest, K.M. Hodivala-Dilke, and C. Dickson A crucial role for Fgfr2-IIIb signalling in epidermal development and hair follicle patterning Development 130 22 2003 5493 5501
16. J.M. Revest, R.K. Suniara, K. Kerr, J.J. Owen, and C. Dickson Development of the thymus requires signaling through the fibroblast growth factor receptor R2-IIIb J Immunol 167 4 2001 1954 1961
17. K. Yu, J. Xu, Z. Liu, D. Sosic, J. Shao, and E.N. Olson Conditional inactivation of FGF receptor 2 reveals an essential role for FGF signaling in the regulation of osteoblast function and bone growth Development 130 13 2003 3063 3074
18. J.S. Colvin, B.A. Bohne, G.W. Harding, D.G. McEwen, and D.M. Ornitz Skeletal overgrowth and deafness in mice lacking fibroblast growth factor receptor 3 Nat Genet 12 4 1996 390 397
19. S. Werner, H. Smola, X. Liao, M. Longaker, T. Krieg, and P. Hofschneider The function of KGF in morphogenesis of epithelium and reepithelialization of wounds Science 266 1994 819 822
20. J. Jameson, K. Ugarte, N. Chen, P. Yachi, E. Fuchs, and R. Boismenu A role for skin gammadelta T cells in wound repair Science 296 5568 2002 747 749
21. S. Werner Keratinocyte growth factor: a unique player in epithelial repair processes Cytokine Growth Factor Rev 9 2 1998 153 165
22. N.J. Meropol, R.A. Somer, J. Gutheil, R.J. Pelley, M.R. Modiano, and E.K. Rowinsky Randomized phase I trial of recombinant human keratinocyte growth factor plus chemotherapy: potential role as mucosal protectant J Clin Oncol 21 8 2003 1452 1458
23. R. Callahan, and G.H. Smith MMTV-induced mammary tumorigenesis: gene discovery, progression to malignancy and cellular pathways Oncogene 19 8 2000 992 1001
24. M. Katoh WNT and FGF gene clusters (review) Int J Oncol 21 6 2002 1269 1273
25. C. Dickson, B. Spencer-Dene, C. Dillon, and V. Fantl Tyrosine kinase signalling in breast cancer: fibroblast growth factors and their receptors Breast Cancer Res 2 3 2000 191 196
26. G. Peters, A. Lee, and C. Dickson Concerted activation of two potential proto-oncogenes in carcinomas induced by mouse mammary tumour virus Nature 320 1986 628 631
27. F. van Leeuwen, and R. Nusse Oncogene activation and oncogene cooperation in MMTV-induced mouse mammary cancer Semin Cancer Biol 6 3 1995 127 133
28. G.M. Shackleford, C.A. MacArthur, H.C. Kwan, and H.E. Varmus Mouse mammary-tumor virus-infection accelerates mammary carcinogenesis in wnt-1 transgenic mice by insertional activation of int-2/fgf-3 and hst/fgf-4 Proc Natl Acad Sci USA 90 2 1993 740 744
29. B.E. Welm, K.W. Freeman, M. Chen, A. Contreras, D.M. Spencer, and J.M. Rosen Inducible dimerization of FGFR1: development of a mouse model to analyze progressive transformation of the mammary gland J Cell Biol 157 4 2002 703 714
30. G.R. Cunha, S.W. Hayward, Y.Z. Wang, and W.A. Ricke Role of the stromal microenvironment in carcinogenesis of the prostate Int J Cancer 107 1 2003 1 10
31. G. Yan, Y. Fukabori, G. McBride, S. Nikolaropolous, and W.L. McKeehan Exon switching and activation of stromal and embryonic fibroblast growth factor (FGF)-FGF receptor genes in prostate epithelial cells accompany stromal independence and malignancy Mol Cell Biol 13 8 1993 4513 4522
32. S. Feng, F. Wang, A. Matsubara, M. Kan, and W.L. McKeehan Fibroblast growth factor receptor 2 limits and receptor 1 accelerates tumorigenicity of prostate epithelial cells Cancer Res 57 23 1997 5369 5378
33. D.M. Ornitz, and P.J. Marie FGF signaling pathways in endochondral and intramembranous bone development and human genetic disease Genes Dev 16 12 2002 1446 1465
34. J. Kandel, E. Bossy-Wetzel, F. Radvanyi, M. Klagsbrun, J. Folkman, and D. Hanahan Neovascularization is associated with a switch to the export of bFGF in the multistep development of fibrosarcoma Cell 66 6 1991 1095 1104
35. J.M. Arbeit, D.C. Olson, and D. Hanahan Upregulation of fibroblast growth factors and their receptors during multi-stage epidermal carcinogenesis in K14-HPV16 transgenic mice Oncogene 13 9 1996 1847 1857
36. J. Jouanneau, G. Moens, Y. Bourgeois, M.F. Poupon, and J.P. Thiery A minority of carcinoma cells producing acidic fibroblast growth factor induces a community effect for tumor progression Proc Natl Acad Sci USA 91 1 1994 286 290
37. J. Jouanneau, J. Plouet, G. Moens, and J.P. Thiery FGF-2 and FGF-1 expressed in rat bladder carcinoma cells have similar angiogenic potential but different tumorigenic properties in vivo Oncogene 14 6 1997 671 676
38. M. Okada-Ban, G. Moens, J.P. Thiery, and J. Jouanneau Nuclear 24 kD fibroblast growth factor (FGF)-2 confers metastatic properties on rat bladder carcinoma cells Oncogene 18 48 1999 6719 6724
39. D. Ricol, D. Cappellen, A. El Marjou, S. Gil-Diez-de-Medina, J.M. Girault, and T. Yoshida Tumour suppressive properties of fibroblast growth factor receptor 2-IIIb in human bladder cancer Oncogene 18 51 1999 7234 7243
40. S.G. Diez de Medina, D. Chopin, A. El Marjou, A. Delouvee, W.J. LaRochelle, and A. Hoznek Decreased expression of keratinocyte growth factor receptor in a subset of human transitional cell bladder carcinomas Oncogene 14 3 1997 323 330
41. D. Cappellen, S. Gil Diez de Medina, D. Chopin, J.P. Thiery, and F. Radvanyi Frequent loss of heterozygosity on chromosome 10q in muscle-invasive transitional cell carcinomas of the bladder Oncogene 14 25 1997 3059 3066
42. D. Cappellen, C. De Oliveira, D. Ricol, S. de Medina, J. Bourdin, and X. Sastre-Garau Frequent activating mutations of FGFR3 in human bladder and cervix carcinomas Nat Genet 23 1 1999 18 20
43. N.C. Cross, and A. Reiter Tyrosine kinase fusion genes in chronic myeloproliferative diseases Leukemia 16 7 2002 1207 1212
44. N.P. Munro, and M.A. Knowles Fibroblast growth factors and their receptors in transitional cell carcinoma J Urol 169 2 2003 675 682
45. A.A. Bakkar, H. Wallerand, F. Radvanyi, J.B. Lahaye, S. Pissard, and L. Lecerf FGFR3 and TP53 gene mutations define two distinct pathways in urothelial cell carcinoma of the bladder Cancer Res 63 23 2003 8108 8112
46. M. Karoui, H. Hofmann-Radvanyi, U. Zimmermann, A. Couvelard, C. Degott, and L. Faridoni-Laurens No evidence of somatic FGFR3 mutation in various types of carcinoma Oncogene 20 36 2001 5059 5061
47. J.H. Jang, K.H. Shin, and J.G. Park Mutations in fibroblast growth factor receptor 2 and fibroblast growth factor receptor 3 genes associated with human gastric and colorectal cancers Cancer Res 61 9 2001 3541 3543
48. B.W. van Rhijn, R. Montironi, E.C. Zwarthoff, A.C. Jobsis, and T.H. van der Kwast Frequent FGFR3 mutations in urothelial papilloma J Pathol 198 2 2002 245 251
49. Trudel S, Ely S, Farooqi Y, Affer M, Robbiani DF, Chesi M, et al. Inhibition of fibroblast growth factor receptor 3 induces differentiation and apoptosis in t(4;14) myeloma. Blood 2004;103(9):3521-8.
50. A. Reiter, J. Sohal, S. Kulkarni, A. Chase, D.H. Macdonald, and R.C. Aguiar Consistent fusion of ZNF198 to the fibroblast growth factor receptor-1 in the t(8;13)(p11;q12) myeloproliferative syndrome Blood 92 5 1998 1735 1742
51. D. Smedley, R. Hamoudi, J. Clark, W. Warren, M. Abdul-Rauf, and G. Somers The t(8;13)(p11;q11-12) rearrangement associated with an atypical myeloproliferative disorder fuses the fibroblast growth factor receptor 1 gene to a novel gene RAMP Hum Mol Genet 7 4 1998 637 642
52. C. Popovici, J. Adelaide, V. Ollendorff, M. Chaffanet, G. Guasch, and M. Jacrot Fibroblast growth factor receptor 1 is fused to FIM in stem-cell myeloproliferative disorder with t(8;13) Proc Natl Acad Sci USA 95 10 1998 5712 5717
53. S. Xiao, S.R. Nalabolu, J.C. Aster, J. Ma, L. Abruzzo, and E.S. Jaffe FGFR1 is fused with a novel zinc-finger gene, ZNF198, in the t(8;13) leukaemia/lymphoma syndrome Nat Genet 18 1 1998 84 87
54. C. Popovici, B. Zhang, M.J. Gregoire, P. Jonveaux, M. Lafage-Pochitaloff, and D. Birnbaum The t(6;8)(q27;p11) translocation in a stem cell myeloproliferative disorder fuses a novel gene, FOP, to fibroblast growth factor receptor 1 Blood 93 4 1999 1381 1389
55. G. Guasch, G.J. Mack, C. Popovici, N. Dastugue, D. Birnbaum, and J.B. Rattner FGFR1 is fused to the centrosome-associated protein CEP110 in the 8p12 stem cell myeloproliferative disorder with t(8;9)(p12;q33) Blood 95 5 2000 1788 1796
56. G. Guasch, C. Popovici, F. Mugneret, M. Chaffanet, P. Pontarotti, and D. Birnbaum Endogenous retroviral sequence is fused to FGFR1 kinase in the 8p12 stem-cell myeloproliferative disorder with t(8;19)(p12;q13.3) Blood 101 1 2003 286 288
57. C. Heath, and N.C. Cross Critical role of STAT5 activation in transformation mediated by ZNF198-FGFR1 J Biol Chem 279 8 2004 6666 6673
58. A. Demiroglu, E.J. Steer, C. Heath, K. Taylor, M. Bentley, and S.L. Allen The t(8;22) in chronic myeloid leukemia fuses BCR to FGFR1: transforming activity and specific inhibition of FGFR1 fusion proteins Blood 98 13 2001 3778 3783
59. S. Roumiantsev, D.S. Krause, C.A. Neumann, C.A. Dimitri, F. Asiedu, and N.C. Cross Distinct stem cell myeloproliferative/T lymphoma syndromes induced by ZNF198-FGFR1 and BCR-FGFR1 fusion genes from 8p11 translocations Cancer Cell 5 3 2004 287 298
60. J. Cortes, M. Albitar, D. Thomas, F. Giles, R. Kurzrock, and A. Thibault Efficacy of the farnesyl transferase inhibitor R115777 in chronic myeloid leukemia and other hematologic malignancies Blood 101 5 2003 1692 1697
61. R. Kurzrock, M. Albitar, J.E. Cortes, E.H. Estey, S.H. Faderl, and G. Garcia-Manero Phase II study of R115777, a farnesyl transferase inhibitor, in myelodysplastic syndrome J Clin Oncol 22 7 2004 1287 1292
62. T. Fioretos, I. Panagopoulos, C. Lassen, A. Swedin, R. Billstrom, and M. Isaksson Fusion of the BCR and the fibroblast growth factor receptor-1 (FGFR1) genes as a result of t(8;22)(p11;q11) in a myeloproliferative disorder: the first fusion gene involving BCR but not ABL Genes Chromosomes Cancer 32 4 2001 302 310